National Survey to Understand Ethical, Legal and Social Issues in Communicating to the Public About Epigenetics
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Jun 5, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is focused on understanding how to better communicate about epigenetics, which is how our environment and behaviors, like pollution, exercise, and smoking, can influence our genes. Many people don’t realize that these factors can "turn on" or "turn off" certain genes, potentially impacting their health. By developing and testing new ways to explain these concepts, the researchers hope to increase the public's understanding and acceptance of epigenetics in healthcare.
To participate in this study, you need to be between 65 and 74 years old, speak English, and identify as one of five racial or ethnic groups, including non-Hispanic White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic Indigenous, or Hispanic. Unfortunately, if you are a genetics expert, you won’t be eligible to join. Once the trial starts, participants will engage in discussions or activities aimed at improving how we talk about these important health issues. This research could help make complicated health information clearer for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • English language speaker,
- Identify as one of five racial/ethnic groups:
- • 1. Non-Hispanic White
- • 2. Non-Hispanic Black,
- • 3. Non-Hispanic Asian
- • 4. Non-Hispanic Indigenous (i.e., Alaska Native/Native Hawaiians/American Indian/Other Pacific Islander)
- • 5. Hispanic (all races)
- Exclusion Criteria:
- • Self-identify as a genetics expert
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported